Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Summary of treatments and efficacy for Blastocystis infection

From: Update on the pathogenic potential and treatment options for Blastocystis sp

Treatment (Dose) Efficacy Reference
Iodoquinole (650 mg t.i.d) 0% [91]
Emetine (100 μg/ml) 50% [92]
Metronidazole (2000 mg s.i.d) 0% [93]
Metronidazole (1500 mg s.i.d) 100% [26]
Metronidazole (750 mg t.i.d) 100% [24]
Metronidazole (750 mg t.i.d) 100% [21]
Metronidazole (500 mg t.i.d) 100% [79]
Metronidazole (250- 750 mg t.i.d) 33% [80]
Metronidazole (750 mg t.i.d) 100% [81]
Metronidazole (1500 mg s.i.d) 80% [94]
Metronidazole (800 mg t.i.d) 0% [30]
Metronidazole (30 mg/kg twice daily) 67% [89]
Nitazoxanide (500 mg t.i.d) 100% [86]
Nitazoxanide (100-200 mg b.i.d for children <12 yr, 500 mg b.i.d for >11 yr) 86% [88]
Nitazoxanide (500 mg t.i.d) 100% [95]
Ornidazole (500 mg t.i.d) 50% [96]
Paromomycin (25 mg/kg t.i.d) 100% [93]
Paromomycin (500 mg t.i.d) 100% [97]
Paromomycin (25 mg/kg t.i.d) 100% [82]
Paromomycin (1000 mg b.i.d) & MZ (750 mg t.i.d) 100% [25]
Saccharomyces boulardii (250 mg b.i.d) 78% [89]
Trimethroprim-SMX 22% [80]
Trimethroprim-SMX (6 mg/kg TMP, 30 mg/kg SMX s.i.d) 95% [98]
Trimethropim- SMX (320 mg TMP, 1600 mg SMX s.i.d) 93% [98]
Trimethroprim- SMX (80 mg TMP, 400 mg SMX t.i.d) 100% [30]
Triple therapy (nitazoxanide, furazolidone and secnidazole) 0% [90]